A detailed history of Guyasuta Investment Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 3,001 shares of LLY stock, worth $2.39 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,001
Previous 2,897 3.59%
Holding current value
$2.39 Million
Previous $2.62 Million 1.37%
% of portfolio
0.18%
Previous 0.18%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $80,302 - $99,842
104 Added 3.59%
3,001 $2.66 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $78,778 - $92,869
-150 Reduced 4.92%
2,897 $1.69 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $9,998 - $13,783
23 Added 0.76%
3,047 $1.64 Million
Q2 2023

Jul 17, 2023

BUY
$350.74 - $468.98 $46,297 - $61,905
132 Added 4.56%
3,024 $1.42 Million
Q1 2023

Apr 28, 2023

SELL
$310.63 - $364.82 $339,207 - $398,383
-1,092 Reduced 27.41%
2,892 $993,000
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $351,132 - $409,139
1,092 Added 37.76%
3,984 $1.46 Million
Q3 2022

Oct 25, 2022

SELL
$296.48 - $337.87 $22,236 - $25,340
-75 Reduced 2.53%
2,892 $935,000
Q2 2022

Jul 21, 2022

BUY
$278.73 - $327.27 $36,234 - $42,545
130 Added 4.58%
2,967 $962,000
Q1 2022

May 03, 2022

BUY
$234.69 - $291.66 $9,387 - $11,666
40 Added 1.43%
2,837 $812,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $126,385 - $163,478
700 Added 33.38%
2,797 $642,000
Q3 2020

Oct 28, 2020

BUY
$146.22 - $169.13 $19,739 - $22,832
135 Added 6.88%
2,097 $310,000
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $22,100 - $26,597
162 Added 9.0%
1,962 $322,000
Q1 2020

Apr 28, 2020

BUY
$119.05 - $147.35 $214,290 - $265,230
1,800 New
1,800 $250,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Guyasuta Investment Advisors Inc Portfolio

Follow Guyasuta Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.